Tag: patents
-
FTC Files Brief Challenging Amgen's Enbrel Monopoly
The FTC has filed an amicus brief in an antitrust case, alleging Amgen illegally extended its monopoly on the biologic drug Enbrel through exclusive patent acquisitions, aiming to protect competition in drug markets.
Politics and GovernmentBusinessHealthFederal GovernmentEconomyMedical ScienceLegal Federal Trade CommissionAmgenEnbrelAntitrustBiologic DrugsPatentsMonopoly
-
Media Monitor: AI-Generated Inventions Face Patent Hurdles in U.S. Law
MIT Technology Review reports that despite AI's role in drug discovery, U.S. patent law currently only recognizes humans as inventors, creating intellectual property challenges for companies like Insilico Medicine.
BusinessScience & TechnologyPolitics and GovernmentLegalArtificial IntelligenceMedical ScienceFederal GovernmentEconomyGeneral Politics AIPatentsIntellectual PropertyDrug DiscoveryInsilico MedicineRyan AbbottUS LawMIT Technology ReviewMITsciencetechnology